Active Bacterial Core Surveillance (ABCs) Report Emerging Infections Program Network : Methicillin-Resistant Staphylococcus aureus, 2008 (Update) by National Center for Immunization and Respiratory Diseases (U.S.). Division of Bacterial Diseases. & Emerging Infections Program Network.
 Ϯ
 Last Updated:  January 30, 2012; See methods and discussion for update explanation.
  File:  Jan12staticfixed 
 
  
Active Bacterial Core Surveillance (ABCs) Report 
Emerging Infections Program Network 
Methicillin-Resistant Staphylococcus aureus, 2008 
(Update) Ϯ
ABCs Areas 
California (3 county San Francisco Bay area); Colorado (5 Denver area county); Connecticut; Georgia (8 county Atlanta area); Maryland (1 Baltimore 
area county); Minnesota (2 metro Twin City counties); New York (1 Rochester county); Oregon (3 county Portland area); Tennessee (1 Nashville 
county).  Note, the population under surveillance changed from 2007 (Bold).   
 
ABCs Population 
The surveillance areas represent 18,300,643 persons 
Source: National Center for Health Statistics bridged-race vintage 2008 postcensal file.   
 
ABCs Case Definition 
Invasive methicillin-resistant Staphylococcus aureus (MRSA) disease:  isolation of MRSA from a normally sterile site in a resident of the surveillance 
area in 2008.  Cases of disease are classified into one of three epidemiologic classifications.  A case is classified as hospital-onset (HO) if the MRSA 
culture was obtained on or after the fourth calendar day of hospitalization, where admission is hospital day 1;  as healthcare-associated 
community-onset (HACO) if the culture was obtained in an outpatient setting  or before the fourth calendar day of hospitalization and had one of 
more of the following: 1) a history of hospitalization, surgery, dialysis, or residence in a long term care facility in the previous year, or 2) the 
presence of a central vascular catheter within 2 days prior to MRSA culture; and as community-associated (CA) if none of the previously mentioned 
criteria are met. 
 
ABCs Methodology 
ABCs personnel routinely contacted all microbiology laboratories serving acute care hospitals in their area to identify cases. Standardized case 
report forms that include information on demographic characteristics, clinical syndrome, and outcome of illness were completed for each identified 
case.  Convenience samples of isolates were collected and sent to CDC for routine testing, including: antimicrobial susceptibility testing, toxin 
testing and SCCmec typing. Pulsed field gel electrophoresis (PFGE) of all isolates was discontinued in 2008;  an inferred PFGE algorithm was 
developed based on microbiologic and molecular characteristics of isolates.  The algorithm has been validated for use with isolates collected 
though this surveillance only (http://www.cdc.gov/HAI/settings/lab/inferred-PFGE-algorithm.html).  Regular laboratory audits were performed to 
ensure completeness of case ascertainment. 
Rates of  invasive MRSA disease among all patients were calculated using  population estimates for 2008.  Cases with unknown race were assigned 
race based on distribution of known race  and gender by EIP site.  Methodology to make national estimates was modified in January 2012 to adjust 
for receipt of dialysis, as well as  age, race, and gender.  Previously reported national estimates were adjusted for age and race only.  Confidence 
intervals  for nationally estimated incidence rates of disease and mortality were calculated based on the gamma distribution (Stat Med, 1997 
16:791-801).   
 
ABCs Results 
ABC Racial/Ethnic Profiles      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Distribution of cases, deaths and PFGE  type by Epidemiological 
Classification 
MRSA 
Class 
No. (Rate)  
Cases b 
No. (Rate)  
Death c 
Inferred PFGE Type (n,%)d 
Tot N USA100 USA300 
USA500/ 
Iberian 
CA 948 (5.2) 92 (0.5) 229 70 (30.6) 147 (64.2) 7 (3.1) 
HCA a 4,580 (25.0) 794 (4.3) 1,193 745 (62.5) 328 (27.5) 101 (8.5) 
HO 1,298 (7.1) 308 (1.7) 338 237 (70.1) 71 (21.0) 28 (8.3) 
HACO 3,282 (17.9) 486 (2.7) 855 508 (59.4) 257 (30.1) 73 (8.6) 
a
 HCA: Healthcare-associated invasive MRSA infections; sum of patients that are 
classified as  either HO or HACO  
b 
n= 88 epidemiologic category unknown 
c
 n=9;  epidemiologic category unknown 
d
 isolates were eligible for testing at CDC 
Race                               No.    (Rate) a          
White  3,375 (25.4) 
Black  2,068 (62.1) 
Other  232 (13.8) 
 
Unknown race (n=776) distributed amongst known 
a 
Cases per 100,000 population for ABCs areas (crude rates) 
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ABCs Discussion 
Surveillance data from 2008 represent the fourth full year of performing population-based surveillance for invasive MRSA infections through the 
Emerging Infections Program/Active Bacterial Core Surveillance Activity.  Several changes in operations, including addition of  new variables to 
capture lower respiratory infections and implementation of an algorithm to infer PFGE type, resulted in some changes in the way data are 
presented in this 2008 Annual Summary.  
 
National estimates and calculate incidence rates adjust for receipt of dialysis, as well as  age, race, and gender.  Previously reported national 
estimates were adjusted for age and race only.   
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National Estimates and Adjusted Incidence Rates of Invasive MRSA 
Infections 
Epidemiologic Class Estimated No. 
Incidence Rate 
(Confidence Interval)a   
CA 15,343 5.05 (4.72-5.4) 
HCA  77,138 25.65 (24.90-26.43)  
HO 21,840 7.18   (6.79-7.6) 
HACO 56,298 18.52 (17.87-19.2) 
Overall 
b
 95,872 31.53  (30.7-32.39) 
a 
National Estimates and Incidence (no. per 100,000 population per year) are 
adjusted for age, race, gender, and receipt of dialysis treatment using 2008 US 
Census Data.  
b 
88 cases could not be classified into an epidemiological category or category is 
unknown and therefore are counted in the overall estimate only.   
Reported Clinical Syndrome by Epidemiological Class 
Syndrome a 
CA 
(n=948) 
HACO 
(n=3,282) 
HO 
(n=1,298) 
Bloodstream infection   
with other syndrome 223 1187 597 
with no other syndrome 536 1670 479 
Pneumonia 155 468 234 
Lower Respiratory Infection b 50 105 94 
Osteomyelitis 120 335 109 
Endocarditis 92 200 46 
Cellulitis 166 284 59 
Wounds     
Surgical c 6 174 44 
Decubitus/Pressure Ulcers 18 101 40 
Other wounds/skin abscesses d 19 39 21 
Traumatic 6 27 11 
a 
Some case patients had more than one syndrome. 
b 
Lower Respiratory Infection is defined as:  a patient with pneumonia 
documented in their discharge summary, who has a positive MRSA non-
sterile respiratory specimen with accompanying chest radiology results 
documenting any of the following: bronchopneumonia/pneumonia, air 
space density/opacity, new or changed infiltrates. 
c
 Combines deep tissue/organ infection and infection of a surgical 
wound, post operatively. 
d 
Category includes skin abscess, necrotizing fasciitis, gangrene, non-
traumatic wounds. 
National Estimates and Adjusted Incidence Rates for Mortality among 
Cases 
Epidemiologic Class Estimated No. Mortality Rate 
(Confidence Interval)a  
CA 1,414 0.52 (0.37-0.71) 
HCA 14,181 4.67 (4.35-5.02) 
HO 5,416 1.78 (1.58-2.00) 
HACO 8,775 2.89 (2.63-3.17) 
Overall b 16,096 5.29 (4.95-5.66) 
a 
National Estimates and Mortality Rate (no. per 100,000 population per year) are 
adjusted for age, race, gender and receipt of dialysis treatment using 2008 US 
Census Data 
b 
20  cases could not be classified into an epidemiological category or category is 
unknown and therefore are counted in the overall estimate only.   
